Investigators plan to test the following hypothesis: PET imaging with small molecule probes, in the form of novel fluorescent dyes with radioactive labels, will demonstrate distinct cerebral patterns of binding in subjects with CTE. These cerebral patterns will differentiate from those of age-matched persons who are cognitively intact or from the patients with other neurodegenerative diseases.